Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone Effects
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone Effects
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume 5, Issue 4, Pages 731-736
Publisher
IOS Press
Online
2015-12-10
DOI
10.3233/jpd-150666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- The role of inflammation in sporadic and familial Parkinson’s disease
- (2013) Michela Deleidi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Poor sleep in PCOS; is melatonin the culprit?
- (2013) N. Shreeve et al. HUMAN REPRODUCTION
- Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson’s disease
- (2012) Almas Siddiqui et al. FREE RADICAL BIOLOGY AND MEDICINE
- The effect of hydrochloride pioglitazone on urinary 8-hydroxy -deoxyguanosine excretion in type 2 diabetics
- (2012) Yuefen Wang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Critical Appraisal of Four IL-6 Immunoassays
- (2012) Dana K. Thompson et al. PLoS One
- Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
- (2012) Daniel Lindqvist et al. PLoS One
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
- (2011) Christine R Swanson et al. Journal of Neuroinflammation
- Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system
- (2010) H. C. Yu et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Dramatic Improvement of Blood Glucose Control after Pioglitazone Treatment in Poorly Controlled Over-weight Diabetic Patients with Myotonic Dystrophy
- (2009) Hiroko ABE et al. ENDOCRINE JOURNAL
- Interleukin-6 Serum Levels in Patients with Parkinson’s Disease
- (2009) Kerly Wollmeister Hofmann et al. NEUROCHEMICAL RESEARCH
- PPARγ stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss
- (2009) Gianluca Miglio et al. NEUROCHEMISTRY INTERNATIONAL
- Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson’s Disease
- (2008) Joanne Clark et al. ANTIOXIDANTS & REDOX SIGNALING
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
- (2008) L P Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peroxisome proliferator-activated receptorsγ (PPARγ) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia
- (2008) Andreas Patzer et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- PGC-1α Integrates Insulin Signaling, Mitochondrial Regulation, and Bioenergetic Function in Skeletal Muscle
- (2008) Ines Pagel-Langenickel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease
- (2008) Chiung-Mei Chen et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search